Home Endosense

Endosense

acquired
Series C
Medical Device Developer
Basic
Enterprise Profile

Basic Information

Endosense SA is a medical device company dedicated to improving the efficacy, safety, and reproducibility of catheter ablation treatments for arrhythmias. Endosense SA's TactiCath® received CE certification in May 2009. It is the first and only force-sensing ablation catheter that provides doctors with real-time, objective measurements of contact force during catheter ablation procedures. TactiCath® has undergone extensive preclinical and clinical testing, and its results have provided a solid evidence base for the feasibility, safety, and value of contact force sensing during catheter ablation.
Endosense SA
Switzerland
51~100 people
January 01, 2003
info@endosense.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Therapeutic Manufacturing
Technology
Electrophysiological Techniques
Concept
Cardiology Department Cardiovascular Disease Adjuvant Therapy Products
Application Scenarios
High-Value Medical Consumables